Pier 88 Investment Partners LLC Ultragenyx Pharmaceutical Inc. Transaction History

Pier 88 Investment Partners LLC

$75.6 Million
Q4 2024

A detailed history of Pier 88 Investment Partners LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 14,090 shares of RARE stock, worth $554,300. This represents 0.78% of its overall portfolio holdings.

Number of Shares

14,090

Previous 22,540 37.49%

Holding current value

$554,300

Previous $1.25 Million 52.72%

% of portfolio

0.78%

Previous 1.65%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$42.07 - $57.72 $355,491 - $487,734	-8,450 Reduced 37.49%	14,090 $592,000
Q3 2024 Nov 05, 2024	SELL	$40.21 - $59.36 $137,920 - $203,604	-3,430 Reduced 13.21%	22,540 $1.25 Million
Q2 2024 Aug 06, 2024	BUY	$37.42 - $51.61 $400,394 - $552,227	10,700 Added 70.07%	25,970 $1.07 Million
Q1 2024 May 10, 2024	SELL	$43.02 - $53.69 $228,866 - $285,630	-5,320 Reduced 25.84%	15,270 $712,000
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $282,714 - $438,282	8,910 Added 76.28%	20,590 $984,000
Q3 2023 Nov 09, 2023	SELL	$34.92 - $46.66 $405,770 - $542,189	-11,620 Reduced 49.87%	11,680 $416,000
Q2 2023 Aug 07, 2023	BUY	$37.35 - $52.15 $57,892 - $80,832	1,550 Added 7.13%	23,300 $1.07 Million
Q4 2022 Feb 08, 2023	SELL	$33.72 - $46.33 $36,754 - $50,499	-1,090 Reduced 4.77%	21,750 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $291,308 - $482,160	7,290 Added 46.88%	22,840 $946,000
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $255,036 - $303,995	3,460 Added 28.62%	15,550 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $391,548 - $514,560	5,025 Added 71.13%	12,090 $1.09 Million
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $119,847 - $150,423	1,300 Added 22.55%	7,065 $673,000
Q1 2021 May 14, 2021	BUY	$106.9 - $167.73 $261,370 - $410,099	2,445 Added 73.64%	5,765 $656,000
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $686,172 - $1.44 Million	-8,130 Reduced 71.0%	3,320 $1.51 Million
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $369,643 - $455,850	-5,065 Reduced 30.67%	11,450 $941,000
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $86,783 - $144,707	1,850 Added 12.62%	16,515 $1.29 Million
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $62,779 - $79,744	1,740 Added 13.46%	14,665 $626,000
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $108,800 - $161,561	2,560 Added 24.7%	12,925 $553,000
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $121,603 - $211,548	3,050 Added 41.7%	10,365 $719,000
Q4 2018 Feb 11, 2019	BUY	$38.89 - $77.3 $10,500 - $20,871	270 Added 3.83%	7,315 $318,000
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $89,403 - $112,236	1,245 Added 21.47%	7,045 $538,000
Q2 2018 Jul 25, 2018	BUY	$48.54 - $85.31 $281,532 - $494,798	5,800 New	5,800 $446,000

Others Institutions Holding RARE

# of Institutions

345

Shares Held

86.7M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.76B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.

Account

Pier 88 Investment Partners LLC Ultragenyx Pharmaceutical Inc. Transaction History